ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 277 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $703,310 | -54.6% | 17,340 | -63.0% | 0.00% | -60.0% |
Q3 2022 | $1,548,000 | -49.3% | 46,843 | -46.0% | 0.01% | -47.4% |
Q2 2022 | $3,056,000 | -0.0% | 86,793 | +30.6% | 0.02% | +26.7% |
Q1 2022 | $3,057,000 | +44.6% | 66,474 | +108.5% | 0.02% | +50.0% |
Q4 2021 | $2,114,000 | -49.0% | 31,878 | -51.9% | 0.01% | -54.5% |
Q3 2021 | $4,142,000 | +43.0% | 66,343 | +89.7% | 0.02% | +46.7% |
Q2 2021 | $2,896,000 | +1721.4% | 34,970 | -64.3% | 0.02% | +1400.0% |
Q2 2017 | $159,000 | +231.2% | 97,875 | +275.0% | 0.00% | – |
Q1 2017 | $48,000 | – | 26,100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |